LEMKEY JOHN G (Chief Financial Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/17/2020ACC: 0001209191-20-050872
Officer· Chief Financial Officer
Since Jun 2018
+180.00
Net shares
Net buyer
$1.2K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
180.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+90.00
Price / share
$13.06
Trade value
$1.18K
% of position
3.0%
9/15/2020
2.97K→3.06K
Total
Net shares
+90.00
Net value
$1.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2020 | A · Award | +90.00 | $13.06 | $1.18K | 3.0% | 2.97K | 3.06K |
| Total | +90.00 | $1.18K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
90.00 shares
Shares
+90.00
Strike price
15.37
Held after
90.00
Exercisable
—
9/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock90.00 shares | 9/15/2020 | A · Award | +90.00 | 15.37 | — | 90.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned15.13M
Total
15.13M indirect15.13M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.13M | Indirect |
| Total | 15.13M | 15.13M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported